Such decrease in the elevated serum ALT, AST, LDH, ALP, and GGT activities and serum total bilirubin level as well as alleviated liver histological architecture and integrity were accompanied with a decrease in the elevated liver LPO, serum Th1 cytokine (TNF-α), serum Th17 cytokine (IL-17), and liver proapoptotic mediators (p53 and caspase-3) expression. The gene discussed is GPT; the disease is medical procedure.